Cartesian Therapeutics, Inc. (RNAC)
7.48
+0.25
(+3.46%)
USD |
NASDAQ |
Jan 21, 14:35
Cartesian Therapeutics Market Cap: 194.51M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Repligen Corp. | 9.487B |
| Cabaletta Bio, Inc. | 223.34M |
| Arcellx, Inc. | 4.103B |
| NovaBay Pharmaceuticals, Inc. | 729.28M |
| Palatin Technologies, Inc. | 15.39M |
Market Cap Related Metrics
| PS Ratio | 83.45 |
| Price | 7.48 |
| Earnings Yield | -34.63% |